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A decade has passed since transmembrane coiled-coil domains 1 (TMCO1) defect
syndrome was identified in 11 undiagnosed patients within the Old Order Amish of
Northeastern Ohio—a disorder characterized by a distinctive craniofacial dysmorphism,
skeletal anomalies and global developmental delay. Twenty seven patients, from
diverse ethnic groups, have been reported with pathogenic TMCO1 variants now
recognized to cause cerebrofaciothoracic dysplasia (CFTD). The implication of
previously uncharacterized TMCO1 within disease has instigated a 10-year journey to
understand the function of TMCO1 protein in Ca2+ homeostasis. TMCO1 is an ER
Ca2+ leak channel which facilitates Ca2+ leak upon ER “overload” through the novel
Ca2+ load activated Ca2+ mechanism. This mini-review brings together the clinical and
scientific advances made since the discovery of TMCO1 deficiency in disease, including
broadened phenotype, understanding of pathophysiology, and implications to patient
management of TMCO1 defect syndrome.
Keywords: TMCO1, CFTD, TMCO1 defect syndrome, CLAC channel, calcium, cerebrofaciothoracic dysplasia

INTRODUCTION
Beginning in the 1960s, inherited disorders among Old Order Amish communities were the
subject of exceptional observational studies (McKusick, 1978) and many conditions still remain
subjects of extensive research. During the last two decades, new technologies and methodologies
in genomic medicine have brought dramatic progress on the studies of genetic disorders in
isolated populations. We share here our decade-long journey to understanding a novel rare genetic
disorder: Transmembrane and coiled-coil domains 1 (TMCO1) defect syndrome; from phenotype
description to functional studies in both cell and animal models, and application of learnings
back to patient management. This endeavor exemplifies how translational genomic medicine can
benefit affected patients and families both within Plain communities and the broader international
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candidate genes (Xin et al., 2010). DNA sequencing revealed a
previously unreported homozygous 2-bp deletion in the TMCO1
gene (c.139_140delAG); this introduces a premature stop codon
and results in a severely truncated protein (p.Ser47Ter). It
co-segregated consistently with disease phenotype (Xin et al.,
2010). Our report, for the first time, showed TMCO1 gene
deficiency being associated with an adverse phenotype in
humans; this condition was therefore designated as TMCO1
defect syndrome.

rare disease community, and demonstrates how a rare genetic
disorder may help us to understand common and essential
biological pathways in human cells.

FROM PATIENTS TO GENE DISCOVERY:
IDENTIFICATION OF TMCO1 DEFECT
SYNDROME IN THE OHIO AMISH
The Amish communities of North America represent unique
populations due to their closed communities and small founding
populations. They descend from Swiss Anabaptist immigrants
who came to the New World in the early eighteenth century.
There is increased incidence of rare recessive disorders in
Amish populations, caused by founder effects. The majority
of affected individuals are homozygous for their respective
pathogenic variant, which resides within a relatively large
homozygous haplotype block. Biological and social aspects of the
Amish communities make them ideal participants for studies in
population genetics and genomic medicine.
High density single-nucleotide polymorphism (SNP)
microarray genotyping has been successfully used in
linkage analysis and genome-wide homozygosity mapping
for undiagnosed recessive conditions within the Amish
communities. Using SNP array genotyping data, a disease locus
can be mapped to one specific chromosome region with a few
affected patients. This historic breakthrough was particularly
significant in identifying genetic causes of rare conditions and
gene discovery before the era of next-generation sequencing
(Puffenberger et al., 2004).
In 2010, we identified a novel autosomal recessive condition
in a group of 11 undiagnosed patients within the Old Order
Amish of Northeastern Ohio with similar clinical phenotypes
(Xin et al., 2010). All were born with normal birth weight
but hypotonia and poor feeding. The shared phenotype
was characterized by distinctive craniofacial dysmorphism,
skeletal anomalies, and global developmental delay. The typical
craniofacial dysmorphism included brachycephaly, highly
arched bushy eyebrows, synophrys, long eyelashes, low-set
ears, microdontism of primary teeth, and generalized gingival
hyperplasia. Medical photographs detailing facial features
can be found within the original article (Xin et al., 2010).
Skeletal anomalies included Sprengel deformity of scapula,
fusion of spine, rib abnormalities, pectus excavatum, and
pes planus. Neurological examination revealed depressed
deep tendon reflexes, unstable gait, and, in some older
patients, intention tremor. Imaging studies demonstrated
mild prominence of ventricles. Sluggish speech with a
loud, hoarse voice was found in all verbal patients (6/11
individuals). Anatomical abnormalities of the genitourinary
system were noted, including renal agenesis, hydronephrosis,
vesicoureteral reflux, hypoplastic labia minora, hydrocele, and
undescended testes. Sudden death occurred in two patients in
their late 20s.
Genome-wide SNP array genotyping and autozygosity
mapping identified a single shared homozygosity region of 3.3
Mb in all patients at chromosome 1q23.3-q24.1 containing 23
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UNDERSTANDING THE FUNCTION OF
THE TMCO1 PROTEIN
TMCO1 is a highly conserved 188 amino acid cation channel
with a predicted molecular mass of 21.2 kD (Iwamuro et al.,
1999). TMCO1 is ubiquitously expressed in human adult
and fetal tissues, with high expression noted in heart, liver,
thymus, prostate, testis, and kidney (Iwamuro et al., 1999; Xin
et al., 2010; Zhang et al., 2010). Sequence analysis predicts
a structure with two transmembrane domains (amino acids
9–31 and 91–109), and a further hydrophobic segment
(amino acids 143–154) (Iwamuro et al., 1999; Wang et al.,
2016), with both the N- and C-termini located in the cytosol
(Wang et al., 2016). Nuclear magnetic resonance studies
have conversely suggested three transmembrane domains.
Native TMCO1 channel structure has remained elusive
due to difficulties in expressing and isolating TMCO1 for
crystallography studies (Zhang et al., 2021). Multiple studies
have indicated that TMCO1 is localized to the endoplasmic
reticulum (ER) membrane and mitochondria (Iwamuro et al.,
1999; Zhang et al., 2010; Wang et al., 2016). TMCO1 is
readily diffusible throughout the ER membrane. Assessment
of channel dynamics through inside-out patch clamping
defined TMCO1 as a Ca2+ -selective cation channel. The
negative charge of pore-lining residue D140 is required
for Ca2+ permeation, with a charge-neutralizing mutation
abrogating Ca2+ extrusion from the ER. No currents are
detectable through the TMCO1 (p.Ser47Ter) mutant protein
(Wang et al., 2016).
The ER is a critical intracellular Ca2+ store, with store load
being finely balanced. Ca2+ homeostasis is regulated through
a balance of Ca2+ uptake via sarcoendoplasmic reticulum
Ca2+ ATPase (SERCA) pumps, and release through Ca2+ leak
channels. ER Ca2+ leak is currently not well defined.
TMCO1 has been established as an ER Ca2+ leak channel
(Wang et al., 2016). Knockdown (KD) of TMCO1 resulted
in ER Ca2+ store overload, indicating loss of endogenous
Ca2+ leak. Store depletion resulted in a two-fold increase
in total Ca2+ released from ER stores in TMCO1 KD cells.
Measurement of ER Ca2+ load showed significant increase in
basal ER Ca2+ concentration (Wang et al., 2016). TMCO1
Amish variant (p.Ser47Ter) expression did not rescue Ca2+
leak, indicating abnormal Ca2+ handling as a mechanism for
the disease phenotype. TMCO1-knockout (KO) mouse showed
severe ER Ca2+ mishandling within osteoblasts and granulosa
cells, although no overload was observed in germinal vesicles
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Understanding the effect of disturbed ER Ca2+ homeostasis
on downstream functions is critical to understand TMCO1
deficiency pathophysiology. TMCO1-KO mouse displays a
disease phenotype consistent with TMCO1 defect syndrome,
including delayed osteogenesis, cognitive disability, and unstable
gait (Wang et al., 2016). Female TMCO1-KO mice additionally
show impaired follicle development, subfertility, and premature
ovarian failure (POF) (Sun et al., 2018).
ER stress has been identified in TMCO1 KD and KO cell
lines and animal models (Sun et al., 2018; Wang et al., 2019).
ER Ca2+ overload due to TMCO1 deficiency results in increased
intracellular and mitochondrial reactive oxygen species (ROS)
and ER stress-mediated apoptosis through the IRE1 pathway
(Sun et al., 2018). ER stress initiates the unfolded protein response
(UPR) and ER-associated degradation (ERAD) (Carreras-Sureda
et al., 2018). Alterations in protein expression profiles have been
observed in TMCO1 deficient cells. Diacylglycerolacyltransferase
(DGAT)-2 is required for the final and rate-limiting step of
triglyceride production. DGAT-2 protein levels, but not mRNA
levels, are reduced in TMCO1 KD cells due to enhanced
ERAD (Wang et al., 2019). This results in impaired fatty acid
(FA) esterification and reduced intracellular lipid droplets (LD)
during ER Ca2+ overload. Store depletion results in LD increase
to normal levels.

(Wang et al., 2016; Sun et al., 2018). This suggests the importance
of other leak channels in different cell types.
TMCO1 functions in a novel Ca2+ -load activated Ca2+
(CLAC) mechanism. Increases of ER Ca2+ concentrations to
“overload” levels result in endogenous TMCO1 monomers and
dimers undergoing oligomerization to form homotetramers.
Tetrameric TMCO1 channel facilitates active Ca2+ leak from
the ER to reduce Ca2+ load to resting ER concentrations
as illustrated in Figure 1 (Wang et al., 2016). The Ca2+ sensing mechanism of TMCO1 has not yet been investigated.
Further studies are required to determine if TMCO1 can selfdetect ER Ca2+ load or whether a secondary Ca2+ -sensing
protein is required.
ER Ca2+ homeostasis is important in maintaining ER
protein synthesis and membrane lipid biogenesis. The
activity of many ER chaperones and foldases utilize Ca2+ as
a cofactor, binding Ca2+ with low affinity (reviewed in
Carreras-Sureda et al., 2018). ER Ca2+ stores are also required
for both store-operated Ca2+ entry (SOCE) and Ca2+ induced Ca2+ release (CICR) signaling. SOCE is an important
signaling mechanism in non-excitable cells: facilitated by
the Ca2+ -release activated Ca2+ (CRAC) channel. CICR
is thought to play an important role in Ca2+ signaling in
cardiac smooth muscle.

FIGURE 1 | Schematic of TMC01 function. TMCO1 exists as monomers and dimers during basal ER Ca2+ load. ER Ca2+ reaching overload results in
oligomerization to form active TMCO1 tetrameric channels, facilitating Ca2+ release. Channels undergo rapid disassembly once basal Ca2+ levels are restored.
Mutated TMCO1 is unable to assemble to form active channels resulting in persistent ER Ca2+ overload.
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include a wide anterior fontanelle, narrow forehead,
posteriorly rotated ears, and jaw anomalies such as
prognathism and micrognathia. Cerebral imaging findings
have been broadened from the ventricle abnormalities
initially described in TMCO1 defect syndrome. Corpus
callosum abnormalities have been reported in 57% of new
TMCO1 defect syndrome cases. Further anomalies within
the cerebellar and frontotemporal lobe have been reported.
Epilepsy has been seen in three cases. Variance in stature is
marked, with 55% individuals > 95th or < 5th centile where
reported in literature. Vertrabral anomalies were described in
80% of new cases.
Key features initially reported by Xin et al have been reinforced
by these additional cases. Most notable craniofacial features
include low hairline, low-set ears, highly arched bushy eyebrows
with synophrys, orbital hypertelorism, and brachycephaly with
a flat face. Skeletal anomalies affecting the spine, ribs and
scapula are common, including rib fusions and spine fusions.
Severe intellectual difficulties have been reported in all cases.
Developmental milestones have not been consistently addressed
in clinical reports; however, 50% of individuals have been
reported as non-verbal, with verbal individuals reported to
have delayed first words, speech defects, and a small limited
vocabulary. Developmental motor milestones are also delayed,
with some individuals unable to walk and significant delay
in age of independent sitting reported. Behavioral problems,
such as anxiety and self-mutilation, have been described
(Xin et al., 2010; Caglayan et al., 2013; Alanay et al.,
2014; Tender and Ferreira, 2018; Michael Yates et al., 2019;
Sharkia et al., 2019).

LDs play a role in the maintenance of mitochondria
and prevention of lipotoxicity by reducing free cytoplasmic
FAs. A reduction in mitochondrial volume due to increased
mitophagy was observed in TMCO1 KO and KD cells.
Mitochondria showed poor morphology including abnormal
cristae morphology and presence of large vacuoles in TMCO1
KO, and mitochondrial respiration was found to be significantly
reduced (Wang et al., 2019). These findings demonstrate
possible mechanisms by which TMCO1 deficiency results in
pathophysiology. Further research is required to understand the
impact of the loss of TMCO1 through ER stress and implications
on Ca2+ signaling.

DEVELOPING OUR CLINICAL
UNDERSTANDING OF DISEASE
GENOTYPE AND PHENOTYPE
Four years after the publication of the TMCO1 defect syndrome,
Alanay et al. identified a pathogenic TMCO1 variant within four
Turkish families diagnosed with cerebrofaciothoracic dysplasia
(CFTD) (Alanay et al., 2014). They proposed that TMCO1
defect syndrome was part of the CFTD spectrum of disorders,
originally identified by Pascual-Castroviejo (Pascual-Castroviejo
et al., 1975). This is supported in subsequent literature. TMCO1
and the 1q24 region were excluded within one family, indicating
that CFTD may be a heterogeneous disorder (Alanay et al., 2014).
Furthermore, the molecular etiology of individuals with a clinical
diagnosis of CFTD, prior to the identification of TMCO1, has
not been reported in literature. “TMCO1 defect syndrome” will
therefore be used within this review to define any individual with
an identified pathogenic variant in TMCO1 causing a clinical
presentation of CFTD.
Twenty-seven patients, from diverse ethnic backgrounds,
are reported in literature as having TMCO1 defect syndrome.
Five further pathogenic variants have been identified. All
identified variants result in a premature termination codon
(PTC), including a splicing variant which results in exon five
skipping and early termination in exon six. Nonsense- mediated
mRNA decay has been proposed for 4/5 variants, with 1/5
variants predicted to produce a non-functional protein product
(Caglayan et al., 2013; Alanay et al., 2014; Pehlivan et al., 2014;
Tender and Ferreira, 2018; Michael Yates et al., 2019; Sharkia
et al., 2019). It is therefore likely that the complete loss of
function of TMCO1 is critical in the pathophysiology of TMCO1
defect syndrome.
An additional five variants have been reported as pathogenic
on ClinVar but not reported in literature (TMCO1[gene], 2020).
4/5 variants also result in early termination, consistent with
variants reported in literature. The 5th variant results in a
frameshift, which is also predicted to produce a truncated protein.
These additional variants indicate a larger patient cohort than
literature suggests.
The increase in patient cohort size has improved
understanding of both disease genotype and phenotype.
Full reported clinical manifestation information is available
within Supplementary Table 1. Additional facial features
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FROM BENCH WORK AND DISEASE
DESCRIPTION TO PRACTICE: CLINICAL
MANAGEMENT OF TMCO1 DEFECT
SYNDROME
TMCO1 defect syndrome phenotype has been well described;
however, disease development over time has been scarcely
reported in literature. Further case reports of individuals may
provide insight into disease progression and the effectiveness
of treatments and interventions. With that in mind, this
mini-review recommends clinical management based on
current evidence.
Assessment of skeletal and neurological abnormalities should
be completed. Speech and language therapy and physical
therapy may provide benefit to individuals. Genital urinary tract
abnormalities have been identified in 37% individuals, including
kidney anomalies in four individuals. Assessment by a renal team
is therefore advisable.
Cardiac anomalies have been reported in three individuals,
including a narrow patent ductus arteriosus (PDA) present at age
4, hypertrophic left ventricle at 9 months, a systolic heart murmur
at birth (Alanay et al., 2014; Michael Yates et al., 2019). A small
PDA has also been reported in clinical diagnosis of CFTD (Cilliers
et al., 2007). Cardiac abnormalities were reported in a fetus from
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issues (McCarl et al., 2009; Feske et al., 2010; reviewed in Putney
et al., 2017). Some phenotypic overlay between TMCO1 defect
syndrome and other disorders associated with CRAC channel
components is notable and further TMCO1 defect studies
may also support wider understanding of the pathology of
CRAC channel defect.
TMCO1 is reported to be ubiquitously expressed in both
embryonic and adult tissues (Iwamuro et al., 1999; Xin et al.,
2010; Zhang et al., 2010). TMCO1 defect syndrome shows
distinct skeletal anomalies and severe developmental delay
consistent with loss of TMCO1 impacting early embryonic tissue
development. Differential expression of TMCO1 in embryos has
not been quantified (Xin et al., 2010). Further study of embryonic
TMCO1 expression and examination of fetal development in
the TMCO1 KO mouse model may improve understanding of
phenotype development.
Loss of ER Ca2+ homeostasis has been shown to increase ER
stress, resulting in UPR, ERAD, and IRE1-dependent apoptosis
and is clearly linked to the pathophysiology of TMCO1 defect
syndrome (Sun et al., 2018; Wang et al., 2019). This is an
area requiring further research, particularly in understanding
the impact on key tissues, including neurons and osteoblasts.
Although aberrant Ca2+ signaling may contribute to TMCO1
defect syndrome phenotype, it seems likely that perturbations in
other ER processes through ER stress mechanisms play a more
principle role. Further translational research with the emphasis
on the normalization of CLAC channel and ER Ca2+ homeostasis
as potential therapeutic approaches is certainly our ultimate hope
for the affected patients and future research direction.

a TMCO1 defect syndrome family (Pehlivan et al., 2014). Sudden
death has additionally been reported (Xin et al., 2010). Cardiology
review and further monitoring is therefore recommended for
TMCO1 defect syndrome patients.
A history of spontaneous abortions has been reported in
families affected by TMCO1 defect syndrome (Xin et al., 2010;
Caglayan et al., 2013; Pehlivan et al., 2014). TMCO1 deficiency
in products of conception has not been confirmed in any
study; however, multiple congenital abnormalities consistent
with TMCO1 defect syndrome have been reported in multiple
fetuses within known TMCO1 defect syndrome families (Alanay
et al., 2014; Pehlivan et al., 2014). The TMCO1 KO mouse model
is reported to have reduced KO pup viability at 8.9% (Wang et al.,
2016). Counseling families about the increased risk of miscarriage
in affected fetuses is therefore advisable.
TMCO1 has been linked with other conditions. Primary
open-angle glaucoma (POAG) is a heritable common cause of
blindness, with a single modifiable risk factor of intraocular
pressure (IOP), which is also highly heritable (Coleman and
Miglior, 2008). GWAS studies have identified numerous risk
loci associated with TMCO1 in both POAG and IOP (Burdon
et al., 2011; van Koolwijk et al., 2012; Choquet et al., 2018;
MacGregor et al., 2018). Individuals homozygous for the
rs4656461 TMCO1 risk allele have been found to develop
glaucoma 4–5 years earlier than non-carriers in families with
a strong family history (Sharma et al., 2012); however, none
of the reported TMCO1-associated risk alleles are located in
coding regions of the TMCO1 gene. It has been proposed
that variants within the regulatory region of TMCO1 confer
increased risk through unknown mechanisms (Burdon et al.,
2011; Sharma et al., 2012). No changes in TMCO1 protein
expression have been demonstrated for those risk alleles and
POAG and IOP have not been reported in TMCO1-deficient
patients. Nevertheless, it is important to monitor IOP in
these patients until understanding of TMCO1 involvement is
further clarified.

SUMMARY
A decade-long journey has defined TMCO1 defect syndrome as
a form of CFTD, and has instigated research in to the function
of TMCO1 protein. The characterization of TMCO1 function
as a novel CLAC channel, with a role in maintaining ER Ca2+
homeostasis, has significantly improved our understanding of the
pathophysiology of CFTD. This is an example of the impact of
rapidly evolving genomic technologies on gene discovery as well
as the consequent improvement of patient management. It also
demonstrates how rare disease studies may help us understand
essential functional pathways in cell biology.

FUTURE RESEARCH
It is now understood that TMCO1 is a CLAC channel with
a role in maintaining ER Ca2+ homeostasis, although how
the deficiency results in the clinical presentation of CFTD
is not fully understood. Improving our understanding of the
pathophysiology of CFTD will be significant in developing
potential treatments to alleviate symptoms.
Further research is required into the regulation of TMCO1dependent Ca2+ leak, including TMCO1 Ca2+ sensing
mechanism and the impact of store overload on store dependent
Ca2+ signaling pathways. Ca2+ signaling has been shown
to be altered due to TMCO1 deficiency but has not been
investigated in depth (Wang et al., 2016; Sun et al., 2018).
Aberrant ER-dependent Ca2+ signaling is associated with
disease. Deficiencies of CRAC channel components, Orai and
STIM, are well known in their link to innate and acquired
immunity. They have also been associated with congenital
myopathies, anhydrosis, dental defects, pancreatitis, and kidney
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